Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  MEDNAX Inc    MD

Delayed Quote. Delayed  - 08/26 10:02:01 pm
62.73 USD   -1.26%
08/15 MEDNAX : Sunrise-based Mednax acquires Fort Myers physician group
08/15 MEDNAX : Announces Acquisition of Maternal-Fetal Medicine Practice i..
08/08 MEDNAX : Sunrise-based Mednax acquires Nevada physician practice
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in  $ Estimates in  $
Fiscal Period December 201320142015201620172018
Sales2 1542 439-3 1853 5353 933
Operating income (EBITDA)492559654686764878
Operating profit (EBIT)452513632598665752
Pre-Tax Profit (EBT)448-----
Net income281317-330369409
P/E ratio19,220,820,017,615,814,2
EPS ( $ )2,783,183,583,553,974,41
Dividend per Share ( $ )------
Yield------
Reference price ( $ )53.3866.1171.6662.7362.7362.73
Announcement Date01/30/2014
11:00am
01/29/2015
11:00am
----
Finances - Leverage
Actuals in  $ Estimates in  $
Fiscal Period December 201320142015201620172018
Debt-515-1 5641 301-
Finance10,4-----
Operating income (EBITDA)492559654686764878
Leverage
(Debt/EBITDA)
-0,92x-2,28x1,70x-
Capital Expenditure15,618,127,128,133,135,5
Book Value Per Share (BVPS)23,2 $22,6 $25,9 $30,2 $32,4 $35,1 $
Cash Flow per Share4,02 $4,23 $3,92 $5,15 $5,46 $5,81 $
Announcement Date01/30/2014
11:00am
01/29/2015
11:00am
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 5 869 M$ -
Entreprise Value (EV) 7 433 M$ 7 170 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 17,6x 15,8x
Capitalization / Revenue 1,84x 1,66x
EV / Revenue 2,33x 2,03x
EV / EBITDA 10,8x 9,38x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 2,07x 1,94x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 18,8% 18,8%
operating Leverage (Delta EBIT / Delta Sales) - 1,02x
Net Margin (Net Profit / Revenue) 10,4% 10,4%
ROA (Net Profit / Asset) 8,00% 8,10%
ROE (Net Profit / Equities) 14,5% 15,2%
Rate of Dividend - -
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   0,88% 0,94%
Cash Flow / Sales 15,1% 14,4%
Capital Intensity (Assets / Sales) 1,29x 1,29x
Financial Leverage (Net Debt / EBITDA) 2,28x 1,70x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend